Acrivon Therapeutics Inc (ACRV) Stock Price, Quote & News

Company Profile

Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops oncology medicines for patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its generative phosphoproteomics platform. The company operates Acrivon Predictive Precision Proteomics (AP3), a precision medicine platform that enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its...

Industry: Biotechnology

Sector: Healthcare

Phone: 617 207 8979

Website: acrivon.com

Address:

480 Arsenal Way, Suite 100, Watertown, United States

Dani_G_German Jun. 8 at 5:14 PM

$ACRV adding on the way down mainly 1.43 - and lower.

0 · Reply

PreGigs Jun. 8 at 4:11 PM

$ACRV I'm still here - this will go up, just a waiting game at this point.

0 · Reply

Dylberts Jun. 6 at 2:34 PM

Glad I sold my position when I did, $ACRV appears to be experiencing a lot of resistance and uncertainty. We may even reach the 52-week low at this rate. The H2 readout will be something important to keep ours eyes out for as this could make or break the 52-week. My current re-entry point is $1.15—$1.30, unless readout is very poor. These are unfortunately the risks of volatile bio stocks, but that said theres still MAJOR upside potential here! Those currently down may benefit from averaging down here if able.

0 · Reply